Neurotech, Neuromodulation, Alzheimers.
announced in January 2021 that its non-invasive neurostimulation device has received breakthrough status from the FDA, to treat cognitive and functional symptoms associated with AD. The company said the device is the first in its pipeline of digital therapeutics for neurodegenerative diseases and